University of Wisconsin - Madison — Madison, Wisconsin

Public research footprint of University of Wisconsin - Madison, compiled from the ClinicalTrials.gov public registry.

471

Registered studies

134

Active

Recruiting now

279

Completed

Stopped or withdrawn

Most-studied conditions

HR Low-Positive/HER2-Negative Breast Neoplasms · Secondary Malignant Neoplasm of Prostate · Deep Vein Thrombosis, Pulmonary Embolus · Healthy Adult

Recently updated registry entries

NCT07173049 — Speech Production Enhancement Using Augmentative Communication for Kids (Recruiting)
NCT06966700 — A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… (Recruiting)
NCT02008357 — Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Wisconsin - Madison?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.